Replies to post #300 on Sinobiopharma, Inc. (fka SNBP)

[pappy]

I believe most bb stocks are a crapshoot.

In the case of snbp the balance sheet is improving rapidly while the pps has made a serious drop due to a large increase in sharecount that has also increased the float.

Even @ the current pps which is about 3x 2011 projected eps or less the pps is having trouble stabilizing.

However as many new drugs start to make their appearance onto the scene snbp will no longer be a 1 product company.

I base my opinion about the future of this company on a experienced managemt team that has the background & know how to deliver many new drugs in the immediate future while continuing to expand on their flagship product that has the potential to go global since it only costs a fraction of a simular U.S. product that is about to lose patent protection.